BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 6364091)

  • 1. The antimicrobial activity of cephalexin against old and new pathogens.
    Jones RN; Preston DA
    Postgrad Med J; 1983; 59 Suppl 5():9-15. PubMed ID: 6364091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A perspective on the present contribution of beta-lactamases to bacterial resistance with particular reference to induction of beta-lactamase and its clinical significance.
    Neu HC; Chin NX
    Chemioterapia; 1985 Feb; 4(1):63-70. PubMed ID: 3872725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vitro antimicrobial activity of desacetylcefotaxime compared to other related beta-lactams.
    Schrinner E; Limbert M; Seeger K; Seibert G; Novick WJ
    Diagn Microbiol Infect Dis; 1984 Jun; 2(3 Suppl):13S-20S. PubMed ID: 6086214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antibacterial properties of cefetamet and in vivo activity of its orally absorbable ester derivative, cefetamet pivoxil.
    Angehrn P; Hohl P; Then RL
    Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):536-43. PubMed ID: 2504597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial activity of ceftriaxone: a review.
    Cleeland R; Squires E
    Am J Med; 1984 Oct; 77(4C):3-11. PubMed ID: 6093515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Summary of laboratory studies on the antibacterial activity of cefaclor.
    Preston DA
    Postgrad Med J; 1979; 55 Suppl 4():22-9. PubMed ID: 398479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of beta-lactamase and PBP amino acid substitutions to amoxicillin/clavulanate resistance in beta-lactamase-positive, amoxicillin/clavulanate-resistant Haemophilus influenzae.
    Matic V; Bozdogan B; Jacobs MR; Ubukata K; Appelbaum PC
    J Antimicrob Chemother; 2003 Dec; 52(6):1018-21. PubMed ID: 14585854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of CGP 31608, a new penem.
    Wise R; Andrews JM; Piddock LJ
    Antimicrob Agents Chemother; 1987 Feb; 31(2):267-73. PubMed ID: 3105451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular correlation between in vitro and in vivo activity of beta-lactam and beta-lactamase inhibitor combinations against methicillin-resistant Staphylococcus aureus.
    Fasola EL; Fasching CE; Peterson LR
    J Lab Clin Med; 1995 Feb; 125(2):200-11. PubMed ID: 7844469
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The in-vitro activity of cefpodoxime: a comparison with other oral cephalosporins.
    Wise R; Andrews JM; Ashby JP; Thornber D
    J Antimicrob Chemother; 1990 Apr; 25(4):541-50. PubMed ID: 2351624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo antibacterial activities of T-2588, a new oral cephalosporin, compared with those of other oral beta-lactam antibiotics.
    Okamoto S; Hamana Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1111-6. PubMed ID: 3499115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of Bay v 3522, a new cephalosporin, compared with activities of other agents.
    Wise R; Andrews JM; Ashby JP; Thornber D
    Antimicrob Agents Chemother; 1990 May; 34(5):813-8. PubMed ID: 2360820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefoperazone: a review of its antimicrobial spectrum, beta-lactamase stability, enzyme inhibition, and other in vitro characteristics.
    Jones RN; Barry AL
    Rev Infect Dis; 1983; 5 Suppl 1():S108-26. PubMed ID: 6221381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of the in vitro spectrum of activity of imipenem.
    Jones RN
    Am J Med; 1985 Jun; 78(6A):22-32. PubMed ID: 3890537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in vitro microbiological activity and stability of cefaclor.
    Gillett AP; Andrews JM; Wise R
    Postgrad Med J; 1979; 55 Suppl 4():9-11. PubMed ID: 44910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefodizime, an aminothiazolylcephalosporin. I. In vitro activity.
    Limbert M; Klesel N; Seeger K; Seibert G; Winkler I; Schrinner E
    J Antibiot (Tokyo); 1984 Aug; 37(8):892-900. PubMed ID: 6090373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.
    Picard M; Malouin F
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2569-72. PubMed ID: 1489208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.
    Ubukata K; Shibasaki Y; Yamamoto K; Chiba N; Hasegawa K; Takeuchi Y; Sunakawa K; Inoue M; Konno M
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1693-9. PubMed ID: 11353613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the new orally active cephalosporin FK027.
    Shigi Y; Matsumoto Y; Kaizu M; Fujishita Y; Kojo H
    J Antibiot (Tokyo); 1984 Jul; 37(7):790-6. PubMed ID: 6381449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance to carbapenems.
    Hawkey PM
    J Med Microbiol; 1997 Jun; 46(6):451-4. PubMed ID: 9379473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.